Breast density changes associated with postmenopausal hormone therapy: Post hoc radiologist-and computer-based analyses

Menopause

Volumn 17, Issue 4, 2010, Pages 772-778

  Nielsen, Mads ^a,b   Pettersen, Paola C ^c   Alexandersen, Peter ^c   Karemore, Gopal ^a,b   Raundahl, Jakob ^b   Loog, Marco ^b   Christiansen, Claus ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NORDIC BIOSCIENCE A S   (Denmark)

^c CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

Breast density; Computer based methods; Oral hormone therapy; Postmenopausal women; Safety

Indexed keywords

DROSPIRENONE; ESTRADIOL; PLACEBO; ANDROSTANE DERIVATIVE; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; ESTROGEN; MINERALOCORTICOID ANTAGONIST; OSTEOCALCIN; PEPTIDE; PEPTIDE FRAGMENT; PROCOLLAGEN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; BREAST; BREAST DENSITY; COMPUTER ANALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONAL THERAPY; HUMAN; MULTIPLE CYCLE TREATMENT; NORMAL HUMAN; POST HOC ANALYSIS; POSTMENOPAUSE; SCORING SYSTEM; BLOOD; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; ESTROGEN THERAPY; FEMUR; LUMBAR VERTEBRA; MAMMOGRAPHY; MIDDLE AGED; PHOTON ABSORPTIOMETRY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL;

ABSORPTIOMETRY, PHOTON; AGED; ALDOSTERONE ANTAGONISTS; ANDROSTENES; BONE DENSITY; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FEMUR; HUMANS; LUMBAR VERTEBRAE; MAMMOGRAPHY; MIDDLE AGED; OSTEOCALCIN; PEPTIDE FRAGMENTS; POSTMENOPAUSE; PROCOLLAGEN; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; COLLAGEN TYPE I; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PEPTIDES;

EID: 77954959857     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181cd4172     Document Type: Article

References (29)

1. Studd J, Pornel B, Marton I, et al. Efficacy and acceptability of intranasal 17 A-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group. Lancet 1999;353:1574-1578.
2. Yesildaglar N, Erkaya S, Uygur D, Gol K, Bingol B, Gunenc Z. Efficacy of pulsed estrogen therapy in relatively younger patients with surgically induced menopause. Hum Reprod 2004;19:210-213.
3. Mattsson LA, Christiansen C, Colau JC, et al. Clinical equivalence of intranasal and oral 17A-estradiol for postmenopausal symptoms. Am J Obstet Gynecol 2000;182:545-552
4. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005; 142:1003-1013.
5. Skouby SO, Al Azzawi F, Barlow D, et al. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri-and postmenopausal hormone replacement therapy. Maturitas 2005;51:8-14.
6. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy post-menopausal women: the Women's Health Initiative randomized trial. JAMA 2003;289:3243-3253.
7. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval-and screen-detected cancers. J Natl Cancer Inst 2000;92:1081-1087.
8. Titus-Ernstoff L, Tosteson AN, Kasales C, et al. Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control 2006;17:1281-1290.
9. Gapstur SM, Lopez P, Colangelo LA, Wolfman J, Van Horn L, Hendrick RE. Associations of breast cancer risk factors with breast density in Hispanic women. Cancer Epidemiol Biomarkers Prev 2003; 12:1074-1080. (Pubitemid 37310265)
10. Boyd NF, Martin LJ, Li Q, et al. Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:961-966
11. A Atlas). Reston, VA: American College of Radiology, 2003.
12. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol 1994;39:1629-1638.
13. Raundahl J, Loog M, Pettersen P, Tanko LB, Nielsen M. Automated effect-specific mammographic pattern measures. IEEE Trans Med Imaging 2008;27:1054-1060.
14. PettersenPC, Raundahl J, Loog M, Nielsen M, Tanko LB, Christiansen C. Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist-and computer-based analyses of mammograms. Climacteric 2008;11:135-143.
15. Warming L, Ravn P, Nielsen T, Christiansen C. Safety and efficacy of drospirenone used in a continuous combination with 17A-estradiol for prevention of postmenopausal osteoporosis. Climacteric 2004;7:103-111.
16. Nielsen M, Raundahl J, Pettersen P, et al. Low dose transdermal estra-diol induces breast density and heterogeneity changes comparable to those of raloxifene. Menopause 2009;16:785-791.
17. Raundahl J, Loog M, Nielsen M. Understanding Hessian-Based Density Scoring. Lecture Notes Comp Sci 2006;4046:447-452.
18. Bremnes Y, Ursin G, Bjurstam N, Lund E, Gram IT. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women. Int J Cancer 2007;120:880-884. (Pubitemid 46175410)
19. Topal NB, Ayhan S, Topal U, Bilgin T. Effects of hormone replacement therapy regimens on mammographic breast density: the role of pro-gestins. J Obstet Gynaecol Res 2006;32:305-308.
20. Pongsatha S, Muttarak M, Chaovisitseree S, Luewan S, Panpanit A. Mammographic changes related to different types of hormonal therapies. J Med Assoc Thai 2006;89:123-129.
21. Marchesoni D, Driul L, Ianni A, et al. Postmenopausal hormone therapy and mammographic breast density. Maturitas 2006;53:59-64.
22. Conner P, Svane G, Azavedo E, et al. Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy. Fertil Steril 2004;81:1617-1623.
23. Sendag F, Cosan TM, Ozsener S, et al. Mammographic density changes during different postmenopausal hormone replacement therapies. Fertil Steril 2001;76:445-450.
24. Lundstrom E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy: dif-ferences according to treatment. Am J Obstet Gynecol 1999;181:348-352.
25. Crandall CJ, Karlamangla A, Huang MH, Ursin G, Guan M, Greendale GA. Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy. Arch Intern Med 2006;166:1578-1584.
26. Harma M, Ozturk A, Harma M. The effect of intranasal 17 A-estradiol on mammographic breast density. Maturitas 2005;52:165-166.
27. Otto C, Fuchs I, Altmann H, et al. Comparative analysis of the uterine and mammary gland effects of drospirenone and medroxyprogesterone acetate. Endocrinology 2008;149:3952-3959.
28. Buist DS, Anderson ML, Taplin SH, LaCroix AZ. The relationship between breast density and bone mineral density in postmenopausal women. Cancer 2004;101:1968-1976.
29. Crandall CJ, Zheng Y, Karlamangla A, et al. The association between mammographic breast density and bone mineral density in the study of women's health across the nation. Ann Epidemiol 2007;17:575-583.